Skip to main content
. 2019 Jun 20;28(8):1086–1096. doi: 10.1002/pds.4836

Figure 1.

Figure 1

A‐F, Six‐monthly prevalence (per 10 000) of codeine for the treatment of pain in children 0‐11 y in (A) Francea, (B‐D) Germanya, (E) Spain, and (F) the United Kingdom. (A) IMS® France (top left corner). (B) IMS® Germany GP (middle top). (C) IMS® Germany PAED (top right corner). (D) IMS® Germany ENT (bottom left corner). (E) BIFAP (middle bottom). (F) CPRD (bottom right corner) ENT = ear, nose, and throat practice, GP = general practice, IMS® = IMS® Disease Analyzer, PAED = paediatric practice. aOwn calculations, based on IMS® Disease Analyzer (France, Germany) [Colour figure can be viewed at wileyonlinelibrary.com]